Genetic Technologies
GENE
#10592
Rank
โ‚น0.34 B
Marketcap
โ‚น71.42
Share price
0.00%
Change (1 day)
-66.04%
Change (1 year)

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2023 the company made an earnings per share (EPS) of -โ‚น3.10 a decrease over its 2022 EPS that were of -โ‚น2.06.

EPS history for Genetic Technologies from 2001 to 2018

Annual EPS

Year EPS Change
2023-โ‚น3.1050.65%
2022-โ‚น2.06-99.04%
2021-โ‚น214.12-46.67%
2020-โ‚น401.47-99.38%
2019-โ‚น64,23610809.09%
2018-โ‚น588.83-41.07%
2017-โ‚น999.22-18.37%
2016-โ‚น1,224-40.24%
2015-โ‚น2,048-53.41%
2014-โ‚น4,397-10.66%
2013-โ‚น4,92171.3%
2012-โ‚น2,873-622.73%
2011โ‚น549.57-108.8%
2010-โ‚น6,245-3.92%
2009-โ‚น6,50073.47%
2008-โ‚น3,74724.96%
2007-โ‚น2,999-10.93%
2006-โ‚น3,366-48.62%
2005-โ‚น6,552-8.31%
2004-โ‚น7,146
2003N/A-100%
2002-โ‚น4,437-9.36%
2001-โ‚น4,895

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,659N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น828.16N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚น473.37N/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น983.14N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น28.01N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
-โ‚น259.28N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น404.27N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น7,162N/A๐Ÿ‡บ๐Ÿ‡ธ USA